Stem Cell Treatment Center to Open in Pennsylvania

A recent study conducted by the University of Pittsburgh suggests that respiratory disease in coal mining areas is more prevalent than in areas that do not pose the same occupational hazards. Pennsylvania is currently the fourth largest coal producing state in the country. Because of this, many cases of occupational lung disease have been reported. Unfortunately, most debilitating lung diseases do not have a cure.

Cellular Treatment Center in Pennsylvania

Many lung disease sufferers have opted in for cellular therapy to improve their quality of life. While cellular therapy isn’t a cure for lung disease, it has improved many patients’ quality of life. The Lung Institute uses cellular therapy to improve lung function. Everyone has cells in their bodies that act as our body’s system to promote healing. Cellular therapy specifically targets damaged areas and accelerates the healing process. The Lung Institute uses a minimally invasive procedure that extracts cells from fat tissue, blood or bone marrow, and reintroduces them back into the body, targeting the damaged lung tissue. Cellular therapy has significantly improved many patients’ lives by allowing them to breathe easier and do the things that they enjoy in life.

Cellular Treatment Center in Pennsylvania

The Lung Institute has completed over 800 treatments in the past two years, and is expanding rapidly. They are looking forward to opening a new clinic in Pittsburgh in July 2015.

About the Staff

Dr. Jack Coleman, Jr., MD, will be the Medical Director of the Pittsburgh clinic. Dr. Coleman earned his medical degree from the University of Cincinnati. He later became an otolaryngology resident at the University of Pittsburgh Eye and Ear Hospital. He also served as a Lieutenant Commander and Commander in the United States Naval Reserve. Dr. Coleman is a diplomate of the National Board of Medical Examiners, is Board Certified in Otolaryngology and is a Fellow of the American Academy of Otolaryngology and Head and Neck Surgery. He is also a member of numerous medical societies including the American Medical Association, American Rhinologic Society, Association of Military Surgeons of the United States and the Pan-American Society of Otolaryngology. Along with his distinguished medical career, Dr. Coleman is a published author for several medical books and is referenced in numerous medical journals.

Although Pittsburgh has some of the highest levels of air pollution in the United States, there is hope for those suffering from COPD. The Lung Institute is on its way.

If you or a loved one suffers from chronic lung disease, contact the Lung Institute to find out if cellular therapy can help get your life back within reach. Contact us by calling 888-745-6697 to see if you qualify.

* Every patient is given a Patient Satisfaction Survey shortly after treatment. Responses to the 11-question survey are aggregated to determine patient satisfaction with the delivery of treatment.

^ Quality of Life Survey data measured the patient’s self-assessed quality of life and measurable quality of improvement at three months of COPD patients.

All claims made regarding the efficacy of Lung Institute's treatments as they pertain to pulmonary conditions are based solely on anecdotal support collected by Lung Institute. Individual conditions, treatment and outcomes may vary and are not necessarily indicative of future results. Testimonial participation is voluntary. Lung Institute does not pay for or script patient testimonials.

As required by Texas state law, the Lung Institute Dallas Clinic has received Institutional Review Board (IRB) approval from MaGil IRB, now Chesapeake IRB, which is fully accredited by the Association for the Accreditation of Human Research Protection Program (AAHRPP), for research protocols and procedures. The Lung Institute has implemented these IRB approved standards at all of its clinics nationwide. Approval indicates that we follow rigorous standards for ethics, quality, and protections for human research.

Each patient is different. Results may vary.